Is Antiphospholipid / Hughes Syndrome contagious?

Antiphospholipid syndrome, also known as Hughes syndrome, is not a contagious disease and cannot be spread from person to person through touch, bodily fluids, or proximity. It is an autoimmune disorder where the body’s immune system mistakenly attacks healthy proteins in the blood, leading to an increased risk of blood clots.

Is Antiphospholipid / Hughes Syndrome contagious in any way?

It is important to state clearly that Antiphospholipid / Hughes syndrome is absolutely not contagious. You cannot "catch" it from someone else, nor can you transmit it to family members, partners, or coworkers. Because it is an autoimmune condition, the immune system produces abnormal antibodies called antiphospholipid antibodies that target the body's own cells. There is no infectious agent—such as a virus, bacteria, or fungus—involved in the development of Antiphospholipid / Hughes syndrome.

What is the actual cause of Antiphospholipid / Hughes Syndrome?

The exact cause of Antiphospholipid / Hughes syndrome remains complex and is likely multifactorial. While the precise trigger for the immune system to begin producing these harmful antibodies is often unknown, researchers have identified several contributing factors:

• Autoimmune dysfunction: The immune system loses its ability to distinguish between foreign invaders and the body’s own healthy tissues.


• Genetic predisposition: While not strictly a hereditary disease, there is evidence that a genetic tendency to develop autoimmune disorders can run in families.


• Environmental triggers: Certain factors, such as severe infections or exposure to specific medications, may act as a catalyst for the onset of symptoms in individuals who are already genetically predisposed.

Why do some people mistakenly think Antiphospholipid / Hughes Syndrome is contagious?

Misunderstandings often arise because Antiphospholipid / Hughes syndrome is a chronic condition that sometimes requires long-term medication, such as blood thinners. Because these medications are sometimes associated with infectious disease treatments in the public consciousness, or because patients may appear unwell during a flare-up, observers may incorrectly assume there is a transmissible element. Furthermore, because it is an "immune" condition, people often conflate it with immune-deficiency diseases that may be caused by viruses. Rest assured, there is no risk to others when living with, touching, or being near someone diagnosed with Antiphospholipid / Hughes syndrome.

How does the DiseaseMaps community approach this diagnosis?

Living with a chronic, invisible illness can feel isolating, especially when others do not understand the nature of your diagnosis. Currently, 451 people with Antiphospholipid / Hughes syndrome have joined the DiseaseMaps community to share their experiences and support one another. Connecting with this community can help combat the stigma associated with autoimmune conditions and provide a space to discuss the reality of managing a non-contagious, chronic health journey with those who truly understand.

Next steps

• Consult a hematologist or a rheumatologist to manage your specific clinical needs and monitor your blood clotting risk factors.


• Educate your friends and family by sharing verified resources that explain the autoimmune, non-contagious nature of Antiphospholipid / Hughes syndrome.


• Join the Antiphospholipid / Hughes syndrome group on DiseaseMaps.org to connect with others and share coping strategies for managing daily life.


• Maintain regular follow-up appointments, as consistent monitoring of blood markers is the gold standard for managing this condition.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Antiphospholipid syndrome.


• Orphanet: Antiphospholipid syndrome (ORPHA:93922).


• Hughes Syndrome Foundation: Understanding the autoimmune nature of the condition.


• PubMed/NCBI: Clinical criteria for the diagnosis of Antiphospholipid Syndrome (Sapporo and Sydney criteria).